Qiao et al. [75] conducted a meta-analysis based on 26 studies with 1968 cases and 2100 controls to evaluate the association between the levels of serum TGF-β1, and urinary TGF-β1 in patients with DM or diabetic nephropathy (DN). Here, TGFB1 is linked to diabetic kidney disease.